Ocular syphilis with optic disc neovascularization treated with bevacizumab evaluated by OCT angiography and electroretinography.

Bevacizumab ERG OCTA Optic disc neovascularization Syphilis

Journal

Journal of ophthalmic inflammation and infection
ISSN: 1869-5760
Titre abrégé: J Ophthalmic Inflamm Infect
Pays: Germany
ID NLM: 101553216

Informations de publication

Date de publication:
30 Oct 2020
Historique:
received: 25 08 2020
accepted: 14 10 2020
entrez: 30 10 2020
pubmed: 31 10 2020
medline: 31 10 2020
Statut: epublish

Résumé

We present our findings in an atypical case of ocular syphilis with optic disc neovascularization that was treated with intravitreal bevacizumab and followed by multimodal imaging and electroretinography. A 29-year-old man presented with a chief complaint of night blindness of one-year duration. Our initial examination showed that an optic disc neovascularization was present, and the optical coherence tomographic (OCT) images showed a reduction in the length of the ellipsoid zone of both eyes. Fluorescein angiography showed leakage from the optic disc neovascular tissue, and the presence of nonperfused areas in the peripheral retina. Blood test was strongly positive for syphilis. He was administered oral amoxicillin and prednisolone. He was also treated with an intravitreal injection of bevacizumab which led to a rapid suppression of the neovascularization. However, panretinal photocoagulation had to be performed because OCT angiography and fluorescein angiography detected residual neovascularization. Although these treatments suppressed the activity of the ocular syphilis, electrophysiological improvements were not seen even 1 year after the initial treatment. OCT angiography and electroretinogram are useful techniques for monitoring the effectiveness of the treatments.

Identifiants

pubmed: 33125583
doi: 10.1186/s12348-020-00219-x
pii: 10.1186/s12348-020-00219-x
pmc: PMC7599286
doi:

Types de publication

Journal Article

Langues

eng

Pagination

28

Références

Doc Ophthalmol. 2012 Jun;124(3):225-36
pubmed: 22457045
Surv Ophthalmol. 1992 Nov-Dec;37(3):203-20
pubmed: 1475754
Case Rep Ophthalmol. 2017 Jan 26;8(1):55-60
pubmed: 28203197
Eye (Lond). 2007 Aug;21(8):1114-9
pubmed: 17024225
Int J Retina Vitreous. 2018 Apr 16;4:15
pubmed: 29692926
Ocul Immunol Inflamm. 2016;24(1):69-76
pubmed: 24960278
Case Rep Ophthalmol. 2012 Sep;3(3):434-7
pubmed: 23341821
Ophthalmology. 1990 Oct;97(10):1281-7
pubmed: 2243678
J Ophthalmic Inflamm Infect. 2016 Dec;6(1):6
pubmed: 26920001
Doc Ophthalmol. 2012 Oct;125(2):169-78
pubmed: 22729668

Auteurs

Gen Miura (G)

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan. gmiura2@chiba-u.jp.

Takayuki Baba (T)

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.

Marie Takeishi (M)

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.

Tomoaki Tatsumi (T)

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.

Hirotaka Yokouchi (H)

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.

Shuichi Yamamoto (S)

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.

Classifications MeSH